-
Site License
-
Site License
-
Enterprisewide
-
Enterprisewide
European HIV/AIDS Drug Markets
Frost & Sullivan, September 1998
This Frost & Sullivan report analyzes the markets for a full range of HIV and AIDS pharmaceutical products, including protease inhibitors, nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, anti-cytomegalovirus drugs and anitfungal drugs. The report examines industry challenges and provides recommendations for spurring growth. It also provides thorough analyses of the competitive field for each product segment in eight European regional markets. Key companies in the industry are profiled.
- Introducing the Market Engineering Consulting Report
- The Market Engineering System
- Market Engineering Report Elements
- Strategic Benefits of Market Engineering for Readers of This Report
- A Word of Caution
- Executive Summary
- Introduction to the European HIV/AIDS Drugs Market
- Summary of Major Findings
- Industry Challenges and Research Methodology
- Identification of Challenges Facing the HIV/AIDS Market
- Time Frame Analysis of Industry Challenges
- Frost & Sullivan's 12-Step Market Engineering Research Methodology
- Market Engineering Forecasting Methodology
- Glossary of Terms
- Market Engineering Research for the Total European HIV/AIDS Drugs Market
- Strategic Analysis and Forecasts of the Total Market
- Presentation of Strategic Significance of Measurements
- Strategic Analysis and Forecasts of the Protease Inhibitors Market
- Strategic Analysis and Forecasts of the NRTI Market
- Strategic Analysis and Forecasts of the NNRTI Market
- Strategic Analysis and Forecasts of the Anti-Cytomegalovirus Market
- Strategic Analysis and Forecasts of the Anti-Fungal Market
- Market Engineering Research for the Benelux HIV/AIDS Drugs Market
- Strategic Analysis and Forecasts of the Protease Inhibitors Market
- Strategic Analysis and Forecasts of the NRTI Market
- Strategic Analysis and Forecasts of the NNRTI Market
- Strategic Analysis and Forecasts of the Anti-Cytomegalovirus Market
- Strategic Analysis and Forecasts of the Anti-Fungal Therapy Market
- Market Engineering Research for the French HIV/AIDS Drugs Market
- Strategic Analysis and Forecasts of the Total Market
- Strategic Analysis and Forecasts of the Protease Inhibitors Market
- Strategic Analysis and Forecasts of the NRTI Market
- Strategic Analysis and Forecasts of the NNRTI Market
- Strategic Analysis and Forecasts of the Anti-Cytomegalovirus Market
- Strategic Analysis and Forecasts of the Anti-Fungal Therapy Market
- Market Engineering Research for the German HIV/AIDS Drugs Market
- Strategic Analysis and Forecasts of the Total Market
- Strategic Analysis and Forecasts of the Protease Inhibitors Market
- Strategic Analysis and Forecasts of the NRTI Market
- Strategic Analysis and Forecasts of the NNRTI Market
- Strategic Analysis and Forecasts of the Anti-Cytomegalovirus Market
- Strategic Analysis and Forecasts of the Anti-Fungal Therapy Market
- Market Engineering Research for the United Kingdom HIV/AIDS Drugs Market
- Strategic Analysis and Forecasts of the Total Market
- Strategic Analysis and Forecasts of the Protease Inhibitors Market
- Strategic Analysis and Forecasts of the NRTI Market
- Strategic Analysis and Forecasts of the NNRTI Market
- Strategic Analysis and Forecasts of the Anti-Cytomegalovirus Market
- Strategic Analysis and Forecasts of the Anti-Fungal Therapy Market
- Market Engineering Research for the Italian HIV/AIDS Drugs Market
- Strategic Analysis and Forecasts of the Total Market
- Strategic Analysis and Forecasts of the Protease Inhibitors Market
- Strategic Analysis and Forecasts of the NRTI Market
- Strategic Analysis and Forecasts of the NNRTI Market
- Strategic Analysis and Forecasts of the Anti-Cytomegalovirus Market
- Strategic Analysis and Forecasts of the Anti-Fungal Therapy Market
- Market Engineering Research for the Spanish HIV/AIDS Drugs Market
- Strategic Analysis and Forecasts of the Total Market
- Strategic Analysis and Forecasts of the Protease Inhibitors Market
- Strategic Analysis and Forecasts of the NRTI Market
- Strategic Analysis and Forecasts of the NNRTI Market
- Strategic Analysis and Forecasts of the Anti-Cytomegalovirus Market
- Strategic Analysis and Forecasts of the Anti-Fungal Therapy Market
- Market Engineering Research for the Scandinavian HIV/AIDS Drugs Market
- Strategic Analysis and Forecasts of the Total Market
- Strategic Analysis and Forecasts of the Protease Inhibitors Market
- Strategic Analysis and Forecasts of the NRTI Market
- Strategic Analysis and Forecasts of the NNRTI Market
- Strategic Analysis and Forecasts of the Anti-Cytomegalovirus Market
- Strategic Analysis and Forecasts of the Anti-Fungal Therapy Market
- Market Engineering Research for the Rest-of-Europe HIV/AIDS Drugs Market
- Strategic Analysis and Forecasts of the Total Market
- Strategic Analysis and Forecasts of the Protease Inhibitors Market
- Strategic Analysis and Forecasts of the NRTI Market
- Strategic Analysis and Forecasts of the NNRTI Market
- Strategic Analysis and Forecasts of the Anti-Cytomegalovirus Market
- Strategic Analysis and Forecasts of the Anti-Fungal Therapy Market
- Market Engineering Strategy
- What Is Market Engineering Strategy?
- How to Improve the Market Engineering Strategy Development Process
- Market Engineering Strategic Recommendations
- Market Engineering Planning in the HIV/AIDS Industry
- Integrating Market Engineering into the Business Planning Process
- Using Market Engineering Planning to Support the Business Planning Process
- Implementation of Market Engineering
- Introduction and Summary
- How to ImplementMarket Engineering in a Company
- How to Make the Most of This Market Engineering Report
- Market Engineering Monitoring of the HIV/AIDS Industry
- The Purpose of Market Engineering Monitoring
- How to Design a Successful Monitoring Programme
- Top Ten Critical Elements of a Market Engineering Programme in the HIV/AIDS Drugs Industry
- Frost & Sullivan's Strategic Recommendations for Further Research
- Profiles of Strategically Targeted Companies
- Abbott Laboratories (1) (708) 937 6100
- Astra AB (46) 8 5532 6000
- Boehringer Ingelheim KG (49) 61 32770
- Bristol-Myers Squibb (1) (212) 546 4000
- Glaxo Wellcome plc (44) 171 493 4060
- Janssen-Cilag (1) (908) 524 0400
- Merck Sharp & Dohme (1) (908) 423 1000
- Pfizer Inc (1) (212) 573 2323
- Pharmacia & Upjohn Inc (1) (908) 360 4400
- Roche Holding Ltd (41) 61 6888 1111
- Database of Key Industry Participants
- Market Participants
- Related Companies
- Table of Figures
- Table of Charts
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW6
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
